Stroke Scale Utilization in Assessing Thrombolytic Eligibility

Stroke Scale Utilization in Assessing Thrombolytic Eligibility

Strokes, whether new or recurrent, affect about 700,000 Americans every year. Stroke is the third leading cause of death in the United States and the number one cause of adult disability. With more than a million hospitalizations occurring in the U.S. each year, the importance of stroke as a major cause of morbidity and mortality cannot be overemphasized. Developments in the area of thrombolytic administration in early stroke management have led to much controversy about lytic therapy and a striking difference in stroke management in hospitals across the country. The literature has made it clear that the medical community should be providing better care for stroke victims across the full spectrum of stroke management.

In this activity, we provide an in-depth review of the administration of the NIH Stroke Scale and the modified NIH Stroke Scale and the assessment of thrombolytic eligibility using the FDA-approved indications and contraindications for tPA administration. We present several cases and provide practitioners with the opportunity to practice assigning a stroke scale score and determining whether or not a patient is a candidate for thrombolytic therapy. After completing this activity, practitioners should be able to: apply an evidence-based stroke scale, such as the NIH Stroke Scale or the modified NIH Stroke Scale, to determine eligibility for thrombolytic agents for patients presenting with stroke in order to provide timely and appropriate stroke management; assess the current indications and contraindications for the use of thrombolytic agents in the management of stroke patients; and create or modify an existing stroke management protocol to include the use of a stroke scale to assist in determining eligibility for thrombolytic agents in patients presenting with stroke in order to provide timely and appropriate stroke management.

  • Provider:The Sullivan Group
  • Activity Link: https://www.thesullivangroup.com/RSQSolutions/course-purchase-home/
  • Start Date: 2022-09-23 05:00:00
  • End Date: 2022-09-23 05:00:00
  • Credit Details: AMA PRA Category 1 Credit™️: 2.0 hours
  • Commercial Support: No
  • Activity Type: Enduring Material
  • CME Finder Type: Online Learning
  • Fee to Participate: Variable
  • Measured Outcome: Learner Competence, Learner Knowledge, Learner Performance, Patient Health
  • Provider Ship: Directly Provided
  • Registration: Open to all
«
Subscribe
Notify of
guest
0 Comments
Oldest
Newest Most Voted
Inline Feedbacks
View all comments
0
Would love your thoughts, please comment.x
()
x

Contact us

If you want to join leaders who will shape what Americans think about sleep.

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.

Sign up for the expert list

for media inquiries

Name(Required)
Sign Up
This field is for validation purposes and should be left unchanged.